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Abstract 
The protein Etp1 of Schizosaccharomyces pombe consists of an amino-terminal COX15-like domain 
and a carboxy-terminal ferredoxin-like domain, Etp1fd, which is cleaved off after mitochondrial 
import. The physiological function of Etp1fd is supposed to lie in the participation in the assembly of 
iron-sulfur clusters and the synthesis of heme A. In addition, the protein was shown to be the first 
microbial ferredoxin being able to support electron transfer in mitochondrial steroid hydroxylating 
cytochrome P450 systems in vivo and in vitro, replacing thereby the native redox partner, 
adrenodoxin. Despite a sequence similarity of 39% and the fact that fission yeast is a mesophilic 
organism, thermodynamic studies revealed that Etp1fd has a melting temperature more than 20 °C 
higher than adrenodoxin. The three-dimensional structure of Etp1fd has been determined by 
crystallography. To the best of our knowledge it represents the first three-dimensional structure of a 
mitochondrial ferredoxin. The structure-based sequence alignment of Etp1fd with adrenodoxin yields a 
rational explanation for their observed mutual exchangeability in the cytochrome P450 system. 
Analysis of the electron exchange with the S. pombe redox partner Arh1 revealed differences between 
Etp1fd and adrenodoxin, which might be linked to their different physiological functions in the 
mitochondria of mammals and yeast.  
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1. Introduction 
Ferredoxins are iron-sulfur proteins which transfer electrons in several physiologically important 
processes such as photosynthesis, respiration and steroid biosynthesis. They are also involved in the 
iron-sulfur cluster assembly in different organisms like bacteria, yeast and mammals. In fission yeast 
(Schizosaccharomyces pombe) the ferredoxin Etp1fd is synthesized as the C-terminal part of the 
protein Etp1, which is comprised of two domains with homology to human proteins. The sequence of 
the approximately 400 N-terminal amino acids shows significant similarity to the COX15 protein [1, 
2], and the C-terminal 127 residues are clearly homologous to vertebrate-type ferredoxins [3]. 
Whereas COX15 is a subunit of the membrane-embedded cytochrome c oxidase complex and 
functions in the respiratory chain, Etp1fd is cleaved off during mitochondrial import [3] and serves in 
the matrix as electron transfer protein. Moreover, an involvement of COX15 together with Etp1fd and 
the putative Etp1fd reductase Arh1 in the hydroxylation of heme O to heme A in the mitochondria of 
S. pombe has been proposed [4, 5]. This assumption was supported by a comprehensive microscopic 
study of the ORFeome project in fission yeast [6], which determined a mitochondrial localization of 
both electron transfer proteins, Arh1 and Etp1fd. Very recently, we demonstrated that the ferredoxin 
reductase Arh1 acts, in fact, as autologous electron donor of Etp1fd and that both proteins together 
provide mammalian class I cytochromes P450 with reduction equivalents in vivo and in vitro [3, 7].  
Arh1 and Etp1fd function in this case as electron carriers in heterologous vertebrate redox systems 
containing human CYP11B1 and CYP11B2, thus enabling the conversion of 11-deoxycortisol to 
cortisol and 11-deoxycorticosterone to aldosterone in fission yeast. The system thereby provides the 
basis for a possible application of fission yeast in biotechnological processes to produce steroid 
hormones [8]. So far, Etp1fd is the only known microbial homologue, which can substitute 
adrenodoxin (Adx) as electron carrier to support the vital steps in steroid biosynthesis, but it has, in all 
probability, an alternative physiological function in yeast mitochondria, because S. pombe does not 
express genes encoding endogenous mitochondrial cytochromes P450 that could act as terminal 
electron acceptors. The homologous proteins in Saccharomyces cerevisiae, the [2Fe-2S] ferredoxin 
Yah1 and Arh1, are described on the cellular level to play an important role in heme A synthesis [4, 5] 
as well as in mitochondrial iron-sulfur cluster assembly on the scaffold protein Isu1 [9, 10]. These 
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observations were made with yeast strains containing mutants of the relevant genes and led to the 
proposal of a general mechanism for both processes, whereas a detailed investigation of the chemical 
mechanism using purified ferredoxin and ferredoxin reductase is still missing for both yeasts. 
However, in case of S. pombe, a protein crosslinking study indicated that Etp1fd closely interacts with 
the key component of iron-sulfur cluster assembly, Isu1 [11, 12].  
So far, no crystal structure of an eukaryotic adrenodoxin-type ferredoxin involved in heme A 
synthesis and assembly of iron-sulfur clusters has been described, whereas three structures of bacterial 
proteins with corresponding function are already solved [13-16]. The corresponding E. coli ferredoxin 
gene was shown to be crucial for the efficient biosynthesis of Fe-S clusters in vivo [17, 18], and the 
encoded protein was proven to support in vitro assembly of Fe-S clusters [19]. To elucidate the 
functional role of this type of ferredoxins in eukaryotes, particularly in mitochondria of the model 
organism fission yeast, we crystallized a truncated version of the adrenodoxin-type ferredoxin, 
Etp1fd(516-618) with 103 amino acids, in analogy to the previously characterized crystal structure of 
the truncated adrenodoxin Adx(4-108) [20]. Here, we describe the structural, thermodynamic and 
functional properties of Etp1fd in comparison with bovine Adx.  
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2. Experimental 
2.1 Cloning, gene expression and protein purification 
Expression of the full-length Etp1fd (127 amino acid residues) using E. coli strain BL21 as expression 
host has been described recently [21]. Because crystallization trials failed with the full-length Etp1fd, 
an expression construct for a truncated protein was generated in strict analogy to the previously 
crystallized construct Adx(4-108).  
Therefore, the expression vector pTrc99a containing the cDNA coding for the ferredoxin domain of 
Etp1 (amino acids 505-631) served as PCR template to produce a shortened cDNA coding for the 
amino acids 516-618. This truncated version of Etp1fd contains the amino acid variation D589N and 
was termed Etp1fd(516-618) throughout the text. The PCR product of Etp1fd(516-618) was also cloned 
in the vector pTrc99a and expressed in E. coli BL21. The gene was expressed at 37 °C in nutrient 
broth medium (peptone meat 5 g/l, peptone gelatin 5 g/l, peptone casein 7 g/l, yeast extract 3 g/l, 
sodium chloride 5 g/l) for 24 h after induction with IPTG. The soluble cell content, obtained after 
sonication and centrifugation, was subjected to ion exchange chromatography on a DEAE column and 
size exclusion chromatography on a Sephadex G-50 column. Collected fractions were analyzed 
spectrophotometrically for their Etp1fd content. Fractions with a Q-value (A415/A276) higher than 0.85 
were harvested, concentrated to a final concentration of 1 mM using Centriprep 10 (Amicon; 
Berverly, MA), and stored at -20 °C until use. 
Recombinant Adx, Etp1fd and Arh1 were purified as described [7, 21, 22]. The protein concentrations 
were calculated with ε414 = 9.8 (mM cm)-1 for Etp1fd  [21] and Adx with ε450 = 11.3 (mM cm)-1 for 
Arh1 [7].  
 
2.2 Electrospray time-of-flight mass spectrometry- 
The mass of Etp1fd(516-618) and Etp1fd(505-631) was determined by electrospray ionization (ESI) 
mass spectrometry using a Q-TOF1 mass spectrometer (Micromass, Manchester, UK) with an 
accuracy of 0.01%. For mass measurements, aliquots of the desalted Etpfd(516-618) solution were 
dried in a vacuum centrifuge and dissolved in a (50:49:1) mixture of methanol, water and formic acid. 
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2.3 EPR spectroscopy 
EPR spectra were recorded on a Bruker ESP300 spectrometer (X-band, 9.5 GHz) equipped with a 
continuous-flow helium cryostat ESR 900 and an ITC 4 temperature controller (Oxford Instruments) 
at 20 K. Parameters in standard measurements were: modulation frequency, 100 kHz; microwave 
power, 2 mW; modulation amplitude, 5 G; time constant, 41 ms. The microwave frequency was 
measured by a HP 5350B frequency counter. The samples after reduction with dithionite were 
transferred in EPR quartz tubes (Wilmad) and frozen in liquid nitrogen.  
Redox titrations were performed for Etp1fd(516-618) in 200 mM potassium phosphate buffer, pH 7.0, 
under strictly anaerobic conditions. The titration vessel was installed in an anaerobic chamber, filled 
with a nitrogen (95%)-hydrogen (5%) gaseous mixture, and stirred under argon gas, purified by 
oxygen adsorbants (Messer Griesheim, Oxysorb). The redox potential was measured by a combined 
micro platinum electrode (Metrohm 6.0408.100) with an Ag/AgCl reference, calibrated against a 
saturated quinhydrone solution, pH 7.0. The redox potential of the system was adjusted with small 
additions of 10, 50 or 100 mM solutions of Na2S2O4 or K3[Fe(CN)6]. After equilibration 150 µl of the 
solution were filled into EPR tubes and immediately frozen in liquid nitrogen. In order to obtain stable 
potentials, the following mediators were used (midpoint potentials at pH 7): potassium 
indigotetrasulfonate (-46 mV), indigocarmine (-125 mV), 2-hydroxynaphthoquinone (-145 mV), 
anthraquinone-1,5- disulfonate (-170 mV), anthraquinone-2-sulfonate (-225 mV), phenosafranine (-
252 mV), safranine T (-289 mV), benzyl viologen (-311 mV), diquat dibromide (-350 mV), and 
methyl viologen (-440 mV). In order to obtain the midpoint potentials for the FeS centers, the 
intensity of the iron-sulfur signals was plotted against the measured redox potential: The fit of data 
points was achieved using the Nernst equation. 
 
2.4 UV-visable (UV-vis) and CD spectroscopy 
Absorption spectra in the UV-vis region were recorded at room temperature on a Shimadzu double-
beam spectrophotometer UV2101PC. NADPH dependent reduction of Etp1fd and Adx was performed 
in 100 mM potassium phosphate buffer (pH 7.4) containing 20 µM ferredoxin, 0.1 µM ferredoxin 
reductase and 20 µM NADPH.  
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Circular dichroism (CD) spectra were recorded at 20 °C on a Jasco J720 spectropolarimeter (Jasco 
Corporation, Tokyo, Japan) in the range between 250 and 650 nm. Samples contained 20 µM 
ferredoxin in 10 mM HEPES buffer (pH 7.4) in a 1 cm cuvette. Temperature-dependent 
measurements were carried out at a heating rate of 50 °C h-1 from 20 to 85 °C with a temperature 
increment of 0.2 °C, monitoring the decrease of the CD signal at 440 nm. Td and Hd were calculated 
from CD scans using the two-state model [23] and the equation 
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Urea unfolding experiments were performed with 20 µM ferredoxin solutions in 10 mM HEPES 
buffer (pH 7.4). Samples were adjusted to the final concentration of denaturant and incubated for 15 
min at 20 °C. The parameters ΔG°u (free energy of unfolding in the absence of denaturant), m 
(cooperativity of unfolding), and Cm (midpoint concentration of denaturant required to unfold half of 
the protein) were calculated with a nonlinear regression function as previously described [24]. 
 
2.5 Functionality of the truncated Etp1fd(516-618) 
In order to analyze the spectral change of the ferredoxins induced by Arh1 and NADPH 10 µM 
solutions of Etp1fd(505-631), Etp1fd(516-618), Adx(1-128) and Adx(4-108) in 50 mM potassium 
phosphate, pH 7.4 containing 0.05 µM Arh1 were mixed with 10 µM NADPH in aerobic and 
anaerobic conditions. Spectra were recorded before, immediately after NADPH addition and after an  
The cytochrome c (Cytc) reaction was carried out as described previously [21]. The samples 
contained 100 µM Cytc, 0.05 µM Arh1, 0.04-4 µM Etp1fd(505-631) or Etp1fd(516-618) and 100 µM 
NADPH. The reaction buffer was 50 mM potassium phosphate, pH 7.4. The reaction was started by 
adding NADPH and measured at room temperature following the reduction of Cytc using ε550 = 
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20,000 M-1 cm-1. Under the conditions employed, Cytc is in large excess, and the derived Km and Vmax 
values are essentially dependent on the interactions in the Arh1- Etp1fd complex. 
 
2.6 Crystallization 
Crystals of Etp1fd(516-618) were obtained at 4 °C by the sitting-drop method using a semi-automated 
dispensing system [25]. The reservoir solution contained 0.04 M HEPES (pH 7.0), 1.8 M Na-citrate, 
3% glycerol and was mixed 1:1 with the protein solution, 18.4 mg ml-1, 20 mM potassium phosphate 
buffer (pH 7.4) resulting in start droplet volumes of 0.6 μl. Because the crystals were temperature 
sensitive and no cryocondition for data sets with resolution better than 3 Å could be found, the 
measurements were performed at 5 °C. 
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2.7 Data collection and structure determination 
The crystals were mounted into polyester tubes using the Room Temperature Mounting System 
MicroRT (MiTeGen, Ithaca, USA). Data sets from two crystals were collected at a Rigaku rotating 
anode generator RU H2B Rigaku Denki, Japan) with a MARDTB 345mm imaging plate detector 
(MarResearch, Norderstedt, Germany). Data were processed, scaled, and merged using XDS and 
XSCALE [26] to 2.6 Å resolution.  
Initial phases for space group P3221 were obtained by molecular replacement with PHASER [27] 
using a model obtained from coordinates of the Adx PDB entries 1e6e, 1ayf, 1l6v and 2bt6 using the 
Automated Protein Modelling Server [28] after removing loop V524-E530. First rigid-body 
refinement of two NCS-related copies of Etp1fd(516-618) within the asymmetric unit with REFMAC 
[29] resulted in Rwork 0.50 and Rfree 0.49. After addition of the [2Fe-2S] clusters, several runs of 
ARPWARP [30] and REFMAC, interrupted with manual corrections in O [31] the final R values are 
Rwork 0.182 and Rfree 0.235. The averaged atomic B value corresponds to the Wilson B factor of 56 Å2. 
No φ/ψ angles are in the disallowed region of the Ramachandran plot. Data collection and refinement 
statistics are summarized in Table 1. The coordinates and diffraction amplitudes were deposited in the 
Protein Data Bank with accession code 2wlb. 
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3. Results and Discussion 
3.1 Expression and functionality of Etp1fd
Although it was shown previously that Etp1fd is cleaved upon import into the mitochondria of fission 
yeast [3], it is still unclear where exactly the cleavage site is localized. Therefore, we prepared two 
Etp1fd  forms, one with a length of 127 amino acids, Etp1fd(505-631) [21], and a truncated variant, 
Etp1fd(516-618), with 103 amino acids, corresponding to the adrenodoxin variants Adx(1-128) and 
Adx(4-108) [32]. Both variants of Etp1fd were expressed as holoproteins in E. coli BL21 and purified 
to homogeneity according to SDS-PAGE analysis. Both proteins were analyzed concerning their 
thermodynamic stability and ability to function as electron transfer protein together with the 
physiological redox partner Arh1. In addition, attempts to crystallize and determine the three-
dimensional structure of these ferredoxins were performed. 
The molecular masses of Etp1fd(516-618) and Etp1fd(505-631) determined by electrospray time-of-
flight mass spectrometry (Micromass, Manchester, U.K.) were 11295.0 and 14096.0 Da, respectively, 
which is in good agreement with the theoretical values of 11296.6 and 14095.9 for both forms. CD, 
UV-vis and EPR spectra indicated that both proteins assembled as holoproteins, because the typical 
signals of ferredoxins due to the FeS cluster were present in all spectra recorded (Fig.1, Fig.2). The 
protein solutions displayed the characteristic brown color of the iron-sulfur cluster and showed Q-
values (A415/A276) of more than 0.85 as described earlier [21]. Protein yields reached more than 20 mg 
l-1 of expression culture for both forms.  
In order to analyze the ability of Etp1fd to accept redox equivalents from the autologous mitochondrial 
redox partner Arh1, both proteins were incubated with NADPH, and changes in the absorbance 
spectra of the ferredoxins upon reduction were followed under aerobic and anaerobic conditions. 
Different samples containing catalytic amounts of Arh1 in combination with both forms of Etp1fd, 
truncated bovine Adx(4-108), and full-length bovine Adx(1-128) were analyzed. Whereas Etp1fd(516-
618), Etp1fd(505-631) and Adx(4-108) barely accept electrons from Arh1, even after an incubation 
time of 5 min and independent of the presence of oxygen, a sample of full-length bovine Adx 
developed, immediately after mixing, an absorbance spectrum of a completely reduced ferredoxin 
(Fig. 2). It is well known that in the absence of an electron acceptor the reduction of Adx leads to an 
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electron leakage reaction in the cytochrome P450 system [33], followed by the production of reactive 
oxygen species (ROS), which inactivate Adx most probably by destroying the iron-sulfur center [34]. 
Our results here demonstrate that Etp1fd, in contrast to Adx, cannot or can hardly be reduced by the 
electron donor Arh1 in the absence of an electron acceptor, which indicates that this protein prevents 
an electron leakage and therefore the destruction of the iron-sulfur center by blocking the electron 
flow from the reductase to the ferredoxin under these conditions. This seems to be ensured by the 
rather low redox potential of Etp1fd, which is closer to that of ISC ferredoxins, compared with 
ferredoxins in cytochrome P450 systems (Table 2). The redox potential of truncated Etp1fd(516-618) 
was determined in this study to be -381±2 mV. The non-truncated Etp1fd(505-631) has a potential of -
353 mV [21], and Adx(1-128) and the truncated Adx(4-108) show values of -273 and -344 mV [35], 
respectively. The values show that the truncation of Etp1fd results in a decrease of the redox potential 
as described for Adx. Considering the values of Etp1fd(505-631), Etp1fd(516-618) and Adx it is 
obvious that the low redox potential of both Etp1fd forms and Adx(4-108) hinders the electron flow to 
the ferredoxins whereas the higher potential of Adx(1-128) allows an electron flow under the same 
experimental conditions. Since the redox potential is one of the main differences between ferredoxins 
of ISC and cytochrome P450 systems [36], we conclude that ISC systems, in general, seem to avoid 
electron leakage and production of destructive ROS by a low redox potential of the involved 
ferredoxins.  
 
Since a direct electron transfer between the redox partners Arh1 and Etp1fd is blocked to a large extent 
and since a physiological electron acceptor for the Etp1fd-Arh1 pair is not available so far, the ability 
of Etp1fd to receive and transfer electrons from Arh1 was analyzed in the presence of the heterologous 
electron acceptor Cytc. Under the applied experimental conditions, the reaction was essentially 
dependent on the interaction in the Arh1-Etp1fd complex, and steady-state kinetic values were 
determined as described earlier for the redox pair Adx and AdR [37]. We could demonstrate that 
Etp1fd(516-618) can accept electrons from Arh1 and donate them to cytochrome c as previously 
described [21]. Even the truncated version Etp1fd(516-618) carrying the replacement D589N is still 
able to transfer electrons in this system. The Vmax values for both variants are in the same order of 
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magnitude being 69.1 ± 1.1 and 65.6 ± 0.5 nmoles Cytc reduced per min. The Km values are 0.36 ± 
0.02 µM and 0.038 ± 0.002 µM for Etp1fd(516-618) and Etp1fd(505-631), respectively.  
Although Etp1fd can also serve as a recombinant electron carrier for mitochondrial cytochrome P450 
enzymes [3], it has obviously an alternative function in yeast, because S. pombe does not express any 
endogenous mitochondrial cytochromes P450 that could act as terminal electron acceptors. 
Interestingly, it was shown recently that two ferredoxins have evolved in human mitochondria, one 
responsible for the electron transfer in the ISC assembly with a redox potential of -342 mV, the other 
one responsible for the electron transfer in the cytochrome P450 system with a potential of -267 mV 
[38].  
 
3.2 Thermodynamic investigation of Etp1fd and determinants of the high thermostability 
Since Etp1fd and Adx obviously serve in different physiological processes, we were wondering 
whether they have different structural and thermodynamic properties. To analyze the protein stability, 
thermal unfolding experiments with the Etp1fd variants were performed. Anaerobic conditions 
prevented the oxidative destruction of the [2Fe-2S] cluster during heating and allowed unfolded 
proteins to regain 95% of the signal intensity after renaturation compared with the original absorption 
spectrum. All ferredoxins were incubated at room temperature in an anaerobic chamber and refolded 
after 12 h. The CD signal of protein melting curves recorded at 440 nm, indicating the integrity of the 
[2Fe-2S] cluster, decreased in a sigmoidal manner (Fig. 1), allowing a data fit according to a two-state 
model. The thermal transition temperatures Tm of the variants Etp1fd(505-631) and Etp1fd(516-618) 
are 70.5 ± 0.7 °C and 65.6 ± 0.5 °C, respectively. The denaturation enthalpy of the transition 
determined at Tm was decreased accordingly by 21 kJ mol-1 in the truncated form. Surprisingly, the Tm 
values are unusually high for a mesophilic organism and significantly higher than the values of 48.9 ± 
0.6 °C and 51.7 ± 0.4 °C reported for the corresponding full-length and truncated forms of Adx [39]. 
Unfolding of the Etp1fd variants using increasing amounts of urea was also followed by CD 
spectroscopy (Fig. 3). The resulting sigmoidal unfolding curves revealed the same tendency for both 
forms as observed in thermal unfolding. The midpoint concentration Cm of urea required to unfold 
half of the variants Etp1fd(505-631) and Etp1fd(516-618) are 4.8 M and 4.0 M, respectively, which 
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indicates also a resistance against urea unusually high for a ferredoxin. The free energy of unfolding 
ΔG°u was 29 ± 3 kJ mol-1 for Etp1fd(516-618). This value is two times higher than the one determined 
for Adx(4-108) (15.3 kJ mol-1) [39].  
The C-terminal part of Adx, which was truncated in Adx(4-108), was shown to be flexible in NMR 
studies [40]. It was also shown that redox-dependent changes of the C-terminus not only exert an 
influence on the binding to the cytochrome P450 but are also responsible for the dissociation of the 
Adx dimer that occurs in the oxidative state [41]. Therefore, it seems to be of advantage for the 
physiological role of Adx that the C-terminus is flexible. The precise physiological function of the C-
terminus in Etp1fd has not been investigated so far, but the loss of stability of the truncated form 
indicates that the C-terminus of Etp1fd is involved in determining the overall structural stability, which 
is in contrast to the function of the C-terminal part in Adx. The reason for the unusually high stability 
of Etp1fd and the opposed stability trend observed after removal of the C-terminus compared with Adx 
remains obscure at present. One might speculate that different electron acceptor proteins in iron-sulfur 
cluster assembly and steroid biosynthesis could require such big differences. However, further studies 
are necessary to investigate this phenomenon. 
 
3.3 Structural comparison of Etp1fd(516-618) and Adx(4-108) 
So far, no 3D structure of a yeast ferredoxin involved in iron-sulfur cluster assembly or heme A 
biosynthesis has been resolved. To better understand the structural basis of these important processes 
it is, however, of great interest to evaluate the structural determinants of these proteins. In order to 
resolve the three-dimensional structure of Etp1fd(516-618) by molecular replacement, search models 
derived from putidaredoxin, terpredoxin, and E. coli ferredoxin were applied unsuccessfully. This 
came as a surprise, since the E. coli ferredoxin was expected to share a closely similar structure with 
Etp1fd and serves an analogous function in iron-sulfur cluster assembly. Finally, molecular 
replacement trials with several modified Adx models proved successful.  
The structural similarity, with root-mean-square deviations (r.m.s.d.) of 1.5 Å for Cα atoms (1.9 Å 
chain B) and 2.1 Å for all atoms (2.5 Å chain B) between the Adx search model and the final structure 
of Etp1fd(518-618) is rather moderate, explaining the difficulties in finding a molecular replacement 
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solution. However, the global architectures of Etp1fd(516-618) and Adx(4-108) are highly similar 
(Fig. 4a). The r.m.s.d. value between the Cα atoms of both ferredoxins, except for a short stretch of 
amino acids (Etp1fd: H546-G554; Adx: V34-G42), is 1.1 Å. It equals the r.m.s.d. value between the 
two molecules of Etp1fd(516-618) within the asymmetric unit of the crystal. The most prominent 
difference between the two Etp1fd(516-618) molecules is observed in loop V524-E530 (Fig. 4c). 
Fitting 94 out of 101 Cα atoms, excluding this loop, results in an r.m.s.d. value of 0.33 Å. This value 
defines the threshold coordinate uncertainty set by experimental errors and crystal lattice effects. 
In order to probe if the sites of functional relevance in Adx are conserved in the structure of Etp1fd an 
alignment of both molecules was performed using the structure of a cross-linked Adx-adrenodoxin 
reductase (AdR) complex [42] (Fig. 5). Superposition of 31 Cα atoms of Etp1fd (A chain), G554-
H566, P580-F592 and R599-Q603, with the corresponding residues of Adx (B chain), G44-H56, I70-
Y82 and R89-Q93, results in an r.m.s.d. value of 0.49 Å. That holds for fitting of Etp1fd(516-618) to 
Adx(4-108) as well as to the Cα backbone of Adx within the covalently cross-linked Adx-AdR 
complex (PDB entry 1e6e, [43]). 
The interaction sites I and II and the electron transfer site of Adx align with the following residues of 
Etp1fd(516-618): 
(i)    interaction site I, E582-D589, main interaction of Adx with AdR (D72-D79) (Fig. 6a), 
(ii)  interaction site II, D551-E553, secondary interaction of Adx with AdR and covalent 
crosslinking site within the Adx-AdR complex (D39-D41) (Fig. 6c), 
(iii)  electron transfer site, A555-T564 and L600-C602, residues near the [2Fe-2S] cluster, 
A45-T54 and L90-C92 in Adx (Fig. 6b).  
In the interaction site I, all acidic residues of Etp1fd are aligning with the corresponding Adx residues. 
D583 of Etp1fd may be involved in CYP11A1 binding similar to E73 of Adx, whereas the other 
residues may bind either to AdR or to CYP11A1 as predicted for Adx [44]. Interaction site II is 
somewhat more distant from the AdR surface in Etp1fd than in Adx, but a slight rigid-body movement 
of Etp1fd may close the gap. The slightly changed structure of Etp1fd could be one reason for the 
reduced efficiency in the substrate conversion with AdR and CYP11A1 [21]. 
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At the electron transfer site (III), the hydrogen bond between E47 of Adx and N63 of AdR [43] can 
also be formed to link E557 of Etp1fd with N63 of AdR. N-terminally, the vicinity of the [2Fe-2S] 
cluster of Etp1fd is significantly changed compared to Adx by a sequence gap (Fig. 7). F43 stacks 
within the hydrophobic core in Adx. It is replaced by E553 in Etp1fd, accompanied by a switching of 
the residue from the inside to the outside of the protein. The F43 cavity is filled by L552 in 
Etp1fd(516-618) (Fig. 6c). Despite the much lower hydrophobicity within its core domain (PONDR 
server [45], results not shown), no water filled funnel is present next to the [2Fe-2S] cluster as 
observed in some of the plant-type ferredoxins [46].  
 
In order to explain the differences in the thermal stability between Etp1fd and Adx, the sequences and 
the crystal structures of both proteins were carefully examined. Overall, the analysis revealed several 
stabilizing intramolecular interactions of a kind previously linked to enhanced protein stability [47] 
and offers an excellent explanation of the increased thermodynamic stability of Etp1fd. The first 
source of the enhanced thermal stability of Etp1fd is the high number of 6 stabilizing salt bridges at the 
protein surface compared to 1 salt bridge in Adx. The second stabilizing factor is a decreased number 
of glycines and an increased number of prolines in loops, which are indicated in Fig. 7. These 
replacements are likely to decrease the conformational entropy upon folding and thus stabilize the 
native fold [48]. A higher thermal stability is also supported by substituting uncharged polar side 
chains by an increased number of charged and hydrophobic residues in Etp1fd and by shortening the 
loop between residues 550-560 in Etp1fd by two amino acids. An additional factor contributing to 
higher thermostability is the helix dipole stabilization [49] due to the replacement of the hydrophobic 
Val34 in Adx by His546 in Etp1fd (Figs. 4, 7). 
 
3.4 Conclusions 
It is demonstrated that Etp1fd shares many structural features with bovine Adx, which explains the 
ability of Etp1fd to replace Adx in various steroid hydroxylase systems. Analyses of the stability of 
Etp1fd revealed that, although being isolated from a mesophilic organism, it shows unusually high 
stability compared with Adx. Structural and sequence data provide a rational explanation for this 
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behavior. In addition, a redox potential based mechanism was discovered preventing iron-sulfur-
cluster destruction by avoiding the formation of reactive oxygen species by the Arh1-Etp1fd complex. 
It needs to be investigated which consequences these observations have on the different physiological 
functions of Etp1fd and Adx.  
 
 
Abbreviations: 
AdR adrenodoxin reductase 
Adx adrenodoxin 
Arh1 adrenodoxin reductase homologue 1 
CD circular dichroism 
COX cytochrome c oxidase 
DEAE diethylaminoethyl 
Etp1fd electron transfer protein ferredoxin domain 
Fdx Ferredoxin 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IPTG isopropyl β-D-1-thiogalactopyranoside 
ISC iron-sulfur cluster 
ORF open reading frame 
PDB protein data bank 
Pdx Putidaredoxin 
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ROS reactive oxygen species 
r.m.s.d. root-mean-square deviations 
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Table 1  
X-ray data collection and refinement statistics. Values in parentheses refer to the outer shell of 
reflections (2.78-2.6 Å). aRmerge =  Σ|I-<I>| / Σ I from two crystals. bRfree = Σ||Fo|-|Fc|| / Σ |Fo|, for test 
data set. cRwork = Σ||Fo|-|Fc|| / Σ |Fo|, where Fo is the observed and Fc is the structure factor amplitude 
calculated from the model. The sum is over all reflections. R for map has been calculated by using the 
EDS-server (eds.bmc.uu.se).Test data set is 5% of the reflections, randomly chosen.d [50]. 
 
Space group P3221 
Resolution [Å] 20 - 2.6 
Observed reflections  28197 (4858) 
Independent reflections 8197 (1396 ) 
<I/σ(I)> 8.5 (3.4) 
Averaged redundancy 3.4 (3.5 ) 
B [Å2], Wilson 56.1 
Completeness: overall / last shell [%] 96.8 (92.4) 
Mosaicity [°] 0.1 
Unit cell a [Å] / c [Å] 81.96 / 68.29 
Rmergea [%]: ov. / last shell 10.9 / 50.9 
 
Amino acids chain A / chain B 516 - 618 / 518 - 618 
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Number all atoms / protein atoms / Fe-S / solvent 1577 / 1567 / 8 / 2 
R / Rworkb / Rfreec [%] 18.4 / 18.2 / 23.5 
R for map [%] 19.7 
r.m.s.d. bond distances [Å] 0.012 
r.m.s.d. bond angles [°] 1.45 
Ramachandran diagram 
Most favored / addit. allowed / gener. allowed / disallowedd [%] 89.7 / 9.7 / 0.6 / 0.0 
Mean B values main chain / side chain / all [Å2] 50.6 / 55.9 / 53.1 
Estimated overall coordinate error (R / Rfree / ML) [Å] 0.26 / 0.28 / 0.20 
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Table 2  
Comparison of redox potentials of ferredoxins involved either in ISC or cytochrome P450 systems.  
 
Ferredoxin Organism Function Redox potential 
EcFdx [14, 19] Escherichia coli ISC system -380 mV 
AvFdx [51] Azotobacter vinelandii ISC system -344 mV 
AaFdxV [52] Aquifex aeolicus ISC system -390 mV 
HsFdx2 [38] Homo sapiens ISC system -342 mV 
Etp1fd [21] Schizosaccharomyces pombe ISC system -353 mV 
BtAdx [53] Bos taurus P450 system -274 mV 
HsFdx1 [38] Homo sapiens P450 system -267 mV 
PpPdx [54] Pseudomonas putida P450 system -235 mV 
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Figure legends 
 
Fig. 1. CD and EPR spectroscopy. A, CD spectra of Etp1fd(505-631) (black line) and Etp1fd(516-
618) (gray line) were recorded in the visible and near UV region. Samples consisted of 25 µM 
ferredoxin in 10 mM HEPES buffer (pH 7.4). B, Fitted single-wavelength thermal unfolding curves of 
Etp1fd(505-631) in black, Etp1fd(516-618) in dark gray and Adx(4-108) in light gray were recorded at 
440 nm, which corresponds to the main CD signal of the iron-sulfur cluster. C) EPR spectra of 
Etp1fd(505-631) (black line) and Etp1fd(516-618) (gray line). Samples of 0.4 mM protein in 10 mM 
potassium phosphate buffer, pH 7.4 were reduced using sodium dithionite under an argon atmosphere 
in a glove box. EPR spectra were recorded on a Bruker ESP300 spectrometer. Both Etp1fd forms 
display identical apparent g-values of g1=2.03 and g2=1.94 typical for vertebrate-type ferredoxins. 
 
Fig. 2. Reduction of ferredoxins. Enzymatic reduction of Adx(1-128) (A), Adx(4-108) (B), 
Etp1fd(505-631) (C) and Etp1fd(516-618) (D). Spectra of ferredoxins in the oxidative state are 
depicted in black. Spectra of ferredoxins immediately after mixing with NADPH and Arh1 are shown 
in gray.  
 
Fig. 3. Urea unfolding of Etp1fd(505-631) and Etp1fd(516-618). CD spectra of Etp1fd(505-631) (A) 
and Etp1fd(516-618) (C) were recorded in the visible and near UV region at urea concentrations 
between 0 and 8 M. In both A and C, the CD signals have the maximum between 0 and 2M and 
minimum intensities with 8 M urea concentrations, respectively. Urea unfolding of Etp1fd(505-631) 
(B) and Etp1fd(516-618) (D) was plotted using data derived from the CD signal at 450 nm, see (A, C). 
 
Fig. 4. Crystal structures of Etp1fd(516-618) and of Adx(4-108) from PDB entry 1ayf. Essential 
functional side chains are labeled and shown in ball-and-stick representation. Etp1fd(516-618) chain A 
is shown in dark yellow (A) and Adx(4-108) chain A in blue. C) Superposition of Etp1fd(516-618) 
chains A, dark yellow, and B, black) and Adx(4-108) (blue) (stereo view). The structurally conserved 
and functionally relevant peptides (44-56, 70-82, 89-93) of Adx were superimposed with the 
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corresponding peptides of Etp1fd (554-566, 580-592, 599-603) using the program LSQKAB [55]. The 
residues discussed in text are shown for Adx (sticks), and for Etp1fd (ball-and-stick). Conserved 
hydrogen bonds are shown as dotted lines. The black arrow marks the loop V524-E530 of Etp1fd(516-
618) chain B. 
 
Fig. 5. Superposition of functional residues from Etp1fd and Adx in complex with AdR. 
Functional residues from Etp1fd(516-618) (Cα trace colored dark yellow) and Adx (Cα trace colored 
blue) are depicted within the covalently crosslinked Adx·AdR complex [42], PDB entry 1e6e. The 
reductase is depicted as a secondary structure plot with the NADP and FAD moieties in ball-and-stick 
representation [56]. 
 
Fig. 6. Superposition of functionally important residues. Stereo view of the superposition of 
functionally important residues in the interaction site I (A), electron transfer site (B), and interaction 
site II (C) of Etp1fd(516-618) and Adx within the Adx·AdR complex (1e6e). AdR residues are colored 
gray, Etp1fd yellow, and Adx blue. Hydrogen bonds between AdR and Adx are shown with dotted 
lines [42]. A predicted electron transfer pathway from FAD to [2Fe-2S] is indicated by red covalent 
bonds and dotted lines in 6B (calculated with HARLEM, [57]). 
 
Fig. 7. Sequence and secondary structure alignment. Sites influencing thermal stability are marked 
in the alignment of bovine Adx(4-108) and Etp1fd(516-618). The extended loop in Adx is highlighted 
cyan, and stabilizing prolines in Etp1fd loops are colored cyan. The V34 to H546 exchange 
accompanied with helix dipole moment enhancement in Etp1fd is marked by a blue bar. Charge 
changes are indicated by correspondingly colored bars (red – negative charge, blue – positive charge). 
The red lines are salt bridges in Etp1fd additional to the internal bridge in Adx and Etp1fd (colored 
magenta). The secondary structure of Adx(4-108) and Etp1fd(516-618) was analyzed using the 
program DSSP [58], green arrows mark β-strands, α-helices are symbolized by brown spirals. 
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